Document:

EX-10.2

 Exhibit 10.2 

FORM OF DIRECTOR CASH AWARD AGREEMENT 

THIS CASH AWARD AGREEMENT (the “Agreement”), effective
                 (the “Agreement Date”), is made by and between Premier, Inc., a Delaware corporation (the “Company”), and the undersigned
non-employee director of the Company (the “Grantee”). The grant date for this Cash Award is                  (the “Grant Date”). 

WHEREAS, in accordance with the terms of the Director Compensation Policy of the Board, the Committee has determined that it would be to the
advantage and best interest of the Company and its stockholders to grant the opportunity to earn the cash award provided for herein to the Grantee as an incentive for efforts during his or her term with the Company, and has advised the Company
thereof and instructed the undersigned officer to enter into this Agreement to evidence this Cash Award opportunity. 
 NOW, THEREFORE, in
consideration of the mutual covenants herein contained and other good and valuable consideration, receipt of which is hereby acknowledged, the parties hereby agree as follows: 

ARTICLE I 
 DEFINITIONS 

Whenever the following terms are used in this Agreement, they shall have the meanings specified below. 

“Board” means the Board of Directors of the Company. 

“Cash Award” shall mean the cash award opportunity provided by the Company to the Grantee as evidenced by this Agreement. 

“Change in Control” shall have the meaning given to it (including any related defined terms) in Section 13.3 of the Premier, Inc. 2013
Equity Incentive Plan (as amended and restated effective December 4, 2015), as amended through the date hereof. 
 “Code” shall mean
the Internal Revenue Code of 1986 (and any successor thereto), as amended from time to time. References to a particular section of the Code include references to regulations and rulings thereunder and to successor provisions. 

“Committee” shall mean the Compensation Committee of the Board. 

“Disability” shall mean any of the following: (i) the Grantee is unable to engage in any substantial gainful activity by reason of any
medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of at least twelve months, or the Grantee’s entitlement to and receipt of disability benefits under
a disability insurance program that pays benefits on the basis of the foregoing definition; (ii) the Grantee is, by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to
last for a continuous period of at least twelve months, receiving disability benefits under a disability insurance program that pays benefits on the basis of the foregoing definition; or (iii) the Grantee is determined to be totally disabled by
the Social Security Administration or Railroad Retirement Board. 

  
 1 

 “Section 409A” shall mean Section 409A of the Code and the applicable regulations or other
guidance issued thereunder. 
 “Separation from Service” shall mean a termination of the Grantee’s service as a director of the Board
(regardless of the reason therefor) that constitutes a separation from service as defined in Section 409A or applicable regulations or other guidance in effect thereunder. 

ARTICLE II 
 GRANT OF CASH AWARD

 2.1    Grant of Cash Award.    The Company has granted to the Grantee on the Grant Date this Cash Award
with respect to the cash amount set forth on the signature page hereto. The grant of the Cash Award has been made in consideration of the services to be rendered by the Grantee to the Board. 

2.2    No Obligation of Service.    Nothing in this Agreement shall confer upon the Grantee any right to
continue in the service on the Board or interfere with or restrict in any way the rights of the Board, which are hereby expressly reserved, to terminate the service of the Grantee at any time for any reason whatsoever. 

2.3    Change in Control.    In order to maintain Grantee’s rights with respect to the Cash Award
evidenced hereby, upon the occurrence of a Change in Control, the Committee may take any actions with respect to the Cash Award or make any modifications to the Cash Award as it deems appropriate to reflect such Change in Control. 

ARTICLE III 
 VESTING OF CASH AWARD

 3.1    Vesting.    Subject to Sections 3.2 and 3.3, the Cash Award shall vest in full on the first
anniversary of the Grant Date. 
 3.2    Acceleration Events.    Notwithstanding the provisions of
Section 3.1: 
  

	 	(a)	In the event of the Grantee’s Disability or death, the Grantee shall immediately vest in a portion of the Cash Award equal to the full amount of the Cash Award granted times a fraction, the numerator of which is
the number of days of active service elapsed since the Grant Date and the denominator of which is 365; and 

  

	 	(b)	In the event that the Grantee is serving as a director on the Board at the time of a Change in Control, the Cash Award shall vest in full. 

3.3    Effect of Separation from Service.    Except as otherwise provided in Section 3.2, no unvested
portion of the Cash Award shall become vested following the Grantee’s Separation from Service, and any unvested portion of the Cash Award shall be immediately and automatically forfeited upon the Grantee’s Separation from Service. 

  
 2 

 ARTICLE IV 

SETTLEMENT OF CASH AWARD 

4.1    Calculation of Settlement Amount.    Subject to the terms of this Agreement, as soon as administratively
feasible following the first to occur of (a) the first anniversary of the Grant Date or (b) the date an acceleration event occurs pursuant to Section 3.2 (each such date, a “Computation Date”), and in no event later than
sixty (60) days following the applicable Computation Date, the Company shall pay to the Grantee the amount of cash equal to such vested portion of the Cash Award. No interest shall accrue or be payable on the Cash Award at any time prior to
payment of such Cash Award. 
 4.2    Forfeiture of Unvested Portion of Cash Award.    To the extent that the
Grantee does not vest in a portion of the Cash Award, all interest in such portion of the Cash Award shall be forfeited upon the Grantee’s Separation from Service. The Grantee has no right or interest in any portion of the Cash Award that is
forfeited. 
 ARTICLE V 

MISCELLANEOUS 
 5.1    Tax
Consequences.    Unless otherwise specifically provided in another agreement between the Company and the Grantee, the Company shall not be liable or responsible for any tax of the Grantee relating to the Cash Award, and the
Grantee agrees to be responsible for, any and all such taxes with respect to the Cash Award. 

5.2    Administration.    The Committee has the power to interpret the Cash Award and this Agreement. All
actions taken and all interpretations and determinations made by the Committee shall be final and binding upon the Grantee, the Company and all other interested persons. No member of the Committee shall be personally liable for any action,
determination or interpretation made in good faith with respect to the Cash Award. In its absolute discretion, the Board may at any time and from time to time exercise any and all rights and duties of the Committee under this Agreement. 

5.3    Cash Award Not Transferable.    Neither the Cash Award nor any interest or right therein or part thereof
shall be liable for the debts, contracts or engagements of the Grantee or his or her successors in interest or shall be subject to disposition by transfer, alienation, anticipation, pledge, encumbrance, assignment or any other means whether such
disposition is voluntary or involuntary or by operation of law by judgment, levy, attachment, garnishment or any other legal or equitable proceedings (including bankruptcy), and any attempted disposition thereof shall be null and void and of no
effect; provided, however, that this Section 5.3 shall not prevent transfers by will or by the applicable laws of descent and distribution. 

  
 3 

 5.4    Section 409A. 

(a) To the extent applicable, this Agreement is intended to comply with Section 409A so that the income inclusion provisions of
Section 409A(a)(1) of the Code do not apply to Grantee, and this Agreement shall be construed, interpreted and administered in a manner that is consistent with this intent and the requirements for avoiding additional taxes or penalties under
Section 409A. Notwithstanding the foregoing, in no event shall the Company be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by the Grantee on account of Section 409A. 

(b) Except as permitted under Section 409A, any nonqualified deferred compensation (within the meaning of Section 409A of the Code)
payable to a Grantee or for the Grantee’s benefit under this Agreement and grants hereunder may not be reduced by, or offset against, any amount owing by the Grantee to the Company or any of its subsidiaries. 

(c) In the event that the Company determines that any amounts payable hereunder may be taxable to the Grantee under Section 409A prior to
the payment and/or delivery to the Grantee of such amount, the Committee may adopt such amendments to the Agreement, and appropriate policies and procedures, including amendments and policies with retroactive effect, that the Committee determines
necessary or appropriate to preserve the intended tax treatment of the benefits provided by the Cash Award and this Agreement. 

5.5    Titles.    Titles are provided herein for convenience only and are not to serve as a basis for
interpretation or construction of this Agreement. 
 5.6    Pronouns.    The masculine pronoun shall include
the feminine and neuter, and the singular the plural, where the context so indicates. 

5.7.    Amendment.    The Committee may amend this Agreement at any time; provided, however, that subject to
Section 5.4 above, no such amendment shall materially impair the rights of the Grantee unless reflected in a writing that is executed by the parties hereto that specifically states that it is amending this Agreement. 

5.8    Severability.    The invalidity or unenforceability of any provision of this Agreement shall not affect
the validity or enforceability of any other provision of this Agreement, and each provision of this Agreement shall be severable and enforceable to the extent permitted by law. 

5.9.    Governing Law.    The laws of the State of Delaware shall govern the interpretation, validity and
performance of this Agreement regardless of the law that might be applied under principles of conflicts of laws. 

5.10    Successors.    All obligations of the Company under this Agreement with respect to the Cash Award shall
be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the Company. 

  
 4 

 5.11    Counterparts.    This Agreement may be executed in
counterparts, each of which shall be deemed an original but all of which together will constitute one and the same instrument. Counterpart signatures to this Agreement transmitted by facsimile, electronic mail, or by any other electronic means
intended to preserve the original graphic and pictorial appearance of a document, will have the same effect as physical delivery of the paper document bearing an original signature. 

[Signature Page to Follow] 

  
 5 

 IN WITNESS WHEREOF, the Company by one of its duly authorized officers has executed this Cash
Award Agreement as of the day and year first above written. 
 PREMIER, INC. 

 

			
		
	By:	 	 
		 	

  

			
	Its:	 	 
		 	

 Please indicate your acceptance of the terms and conditions of this Cash Award Agreement by signing in the space provided below
and returning a signed copy of this Cash Award Agreement to the Company. IF A FULLY EXECUTED COPY OF THIS CASH AWARD AGREEMENT HAS NOT BEEN RECEIVED BY THE COMPANY BY
                        , THE AWARD UNDER THIS CASH AWARD AGREEMENT SHALL BE CANCELLED. 

BY SIGNING BELOW, YOU ACKNOWLEDGE AND AGREE THAT YOU HAVE RECEIVED A COPY OF THIS CASH AWARD AGREEMENT AND ARE FAMILIAR WITH THE TERMS AND PROVISIONS
THEREOF. YOU HAVE REVIEWED THIS CASH AWARD AGREEMENT IN ITS ENTIRETY, HAVE HAD AN OPPORTUNITY TO OBTAIN THE ADVICE OF COUNSEL PRIOR TO EXECUTING THIS CASH AWARD AGREEMENT AND FULLY UNDERSTAND ALL PROVISIONS OF THIS CASH AWARD
AGREEMENT. FINALLY, YOU HEREBY AGREE TO ACCEPT AS BINDING, CONCLUSIVE AND FINAL ALL DECISIONS OR INTERPRETATIONS OF THE COMMITTEE (OR THE BOARD, AS APPLICABLE) UPON ANY QUESTIONS ARISING UNDER THIS CASH AWARD AGREEMENT. 

The undersigned hereby accepts, and agrees to, all terms and provisions of this Cash Award Agreement. 

 

			
		
	By:	 	 
		 	

  

			
	Name:	 	 
		 	

  

			
	Cash Award Amount:tlog_Ex10-1

		
			Exhibit 10.1
		

		
			CONSULTING AGREEMENT
		

		
			 
		

		
			This Consulting Agreement (this “Agreement”) is entered into this 2nd day of May, 2016 (the “Effective Date”) by and between TetraLogic Pharmaceuticals Corporation (“TetraLogic"), a Delaware corporation with its principal place of business located at 343 Phoenixville Pike, Malvern, PA 19355 and Peter Meyers (“Consultant”), having an address at 121 Ridgeway Street, Mount Vernon, NY 10552.
		

		
			 
		

		
			1.         Services.  Consultant will provide TetraLogic with the full benefit of Consultant knowledge, experience and skill with respect to continuing the executing on all third party business collaborations and relationships. These may include, but is not limited to the sale or license of the Company and/or some or all Company assets.   Consulting time will be agreed to by TetraLogic and the Consultant on an as needed basis and will continue for the term of the Agreement. 
		

		
			 
		

		
			2.         Compensation & Expenses.  TetraLogic shall pay Consultant for Services as a one lump sum amount of $265,000.  Payment to be made within 30 days of the start of this contract.   TetraLogic will reimburse Consultant for reasonable and customary travel expenses incurred by Consultant at TetraLogic's request, provided Consultant makes travel arrangements involving air travel through TetraLogic.  All reimbursement expenses shall be paid by TetraLogic to Consultant within 30 days of submission by Consultant of statements and vouchers/receipts.  Consultant shall itemize all such travel expenses on a TetraLogic expense report and each report shall be accompanied by substantiating receipts or vouchers. 
		

		
			 
		

		
			3.         Term of Agreement.  The Consultant’s engagement will begin on the Effective Date of this agreement and terminate on December 1, 2016 unless earlier terminated by TetraLogic upon written notice to Consultant.  The Consultant’s obligations under Sections 4, 5, 6 and 7 shall survive the termination of the Consultant’s engagement until five (5) years after the last disclosure of Confidential Information hereunder.
		

		
			 
		

		
			4.         Confidential Information
		

		
			 
		

		
			(a)         “Confidential Information” means any information, materials or methods, of a business, scientific, clinical, or other nature, in whatever form or embodiment, that has not been made available by TetraLogic to the general public and any information, materials or methods derived therefrom, except that Confidential Information shall not include any information, material or method that:
		

		
			 
		

		
			(i)         at the time of disclosure is in, or after disclosure becomes part of, the public domain, through no improper act on the part of Consultant or any of its employees or contractors;
		

		
			 
		

		
			(ii)        was in Consultant’s possession at the time of disclosure, as shown by written evidence, and was not acquired, directly or indirectly, from TetraLogic;
		

		
			 
		

		
			(iii)       Consultant receives from a third party, provided that such Confidential Information was not obtained by such third party, directly or indirectly, from TetraLogic; or
		

		
			

		 

 

 
		

		
			(iv)       can be demonstrated by written evidence to have been independently developed by Consultant without reference to Confidential Information.
		

		
			 
		

		
			Specific information disclosed as part of the Confidential Information shall not be deemed to be in the public domain or in the prior possession of Consultant merely because it is embraced by more general information in the public domain or in the prior possession of the Consultant.  To the extent that Confidential Information disclosed hereunder comes under any of the exceptions referred to above, Consultant will not disclose that such Confidential Information was acquired from TetraLogic.  Failure to mark any of the Confidential Information as confidential or proprietary shall not affect its status as Confidential Information under the terms of this Agreement.
		

		
			 
		

		
			(b)         Consultant shall keep all Confidential Information confidential, and Consultant shall not disclose Confidential Information to any third party, or use Confidential Information except to perform the Services.  Consultant shall, at a minimum, take those precautions with respect to the Confidential Information that Consultant uses to protect Consultant’s own confidential information.  
		

		
			 
		

		
			(c)         If Consultant becomes required under compulsion of legal process to disclose Confidential Information, Consultant will not, unless required by law, order, regulation or ruling, disclose Confidential Information until TetraLogic has first (a) received prompt written notice of such requirement to disclose and (b) had an adequate opportunity to obtain a protective order or other reliable assurance that confidential treatment will be accorded to the Confidential Information.  Consultant shall provide TetraLogic with reasonable assistance and shall not oppose actions by TetraLogic to assure confidential treatment.  If TetraLogic is unable to obtain such protective order or other appropriate remedy, Consultant will furnish only that portion of the Confidential Information which it is legally required to furnish.  Any disclosure of Confidential Information pursuant to this Section shall not effect or lessen Consultant’s obligations of confidentiality and non-use as expressed herein.
		

		
			 
		

		
			(d)         On TetraLogic’s request, or upon the termination or expiration of this Agreement, whichever is earlier, Consultant shall immediately: (i) stop using Confidential Information; (ii) return all materials provided by TetraLogic to Consultant that contain Confidential Information, except for one copy that may be retained by Consultant’s legal counsel to confirm compliance with the obligations under this Agreement; (iii) destroy all copies of Confidential Information in any form including Confidential Information contained in computer memory or data storage apparatus or materials prepared by or for Consultant; and (iv) provide a written warranty to TetraLogic that Consultant has taken all the actions described in the foregoing Subparagraphs 4(c)(i-iii).
		

		
			 
		

		
			5.         Property.  Consultant may remove materials containing Confidential Information from TetraLogic’s premises only with the express, prior consent of TetraLogic and only for as long as necessary to perform the Services and Consultant shall return all such materials and all copies thereof promptly but in any event no later than the date of termination or expiration of this Agreement.
		

		
			 
		

		
			6.         Intellectual Property.  TetraLogic shall be the sole and exclusive owner of any and all  writings, documents, works made for hire, inventions, discoveries, know-how, processes, chemical 

		 

		

			-2-

		

 

entities, compounds, plans, memoranda, tests, research, designs, specifications, models and data that Consultant makes, conceives, discovers or develops, either solely or jointly with any other person in performance of the Services (collectively, “Work Product”).  Consultant shall promptly disclose to TetraLogic all information relating to Work Product.  Consultant acknowledges that all of the Work Product that is copyrightable shall be considered a work made for hire under United States Copyright Law.  To the extent that any copyrightable Work Product may not be considered a work made for hire under Copyright Law or to the extent that, notwithstanding the foregoing provisions, Consultant may retain an interest in any Work Product that is not copyrightable, Consultant hereby irrevocably assigns and transfers to TetraLogic, and to the extent that an executory assignment is not enforceable, Consultant hereby agrees to assign and transfer to TetraLogic, in writing, from time to time, upon request, any and all right, title, or interest that Consultant has or may obtain in any Work Product without the necessity of further consideration.  TetraLogic shall be entitled to obtain and hold in its own name all copyrights, patents, trade secrets and trademarks with respect thereto.  At TetraLogic’s request and expense including fees paid to for the Consultant's time, Consultant shall assist TetraLogic in acquiring and maintaining its right in and title to, any Work Product.  Such assistance may include, but will not be limited to, signing applications and other documents, cooperating in legal proceedings, and taking any other steps considered necessary or desirable by TetraLogic. 
		

		
			 
		

		
			7.         Restrictive Covenants.  During the term of this Agreement and for two (2) years thereafter, Consultant shall not:
		

		
			 
		

		
			(a)        interfere with any formal or informal business or other relationship between TetraLogic and any third party; or
		

		
			 
		

		
			(b)        contact any of the TetraLogic’s then current personnel, whether employees or independent contractors to offer such personnel employment, except that this prohibition shall not prevent any of such personnel (whether employees or independent contractors) from initiating contact with Consultant for the purpose of obtaining employment.
		

		
			 
		

		
			8.         Consultant’s Obligations to Employer/Third Parties. It is Consultant’s responsibility to ensure that Consultant’s services to TetraLogic do not employ proprietary information of his employer or of any other third party or make use of his employer's or other third party's time or resources without the written agreement of his employer or other third party.
		

		
			 
		

		
			9.         Representations.  Consultant represents that Consultant is not subject to any other agreement that Consultant will violate by signing this Agreement.  
		

		
			 
		

		
			10.       Debarment.  Consultant represents that Consultant has not been debarred, or been the subject of debarment proceedings, by the U.S. Food and Drug Administration.  If, at any time during the term of this Agreement, Consultant (a) becomes debarred, or (b) receives notice of action or threat of action with respect to its debarment, Consultant shall notify TetraLogic immediately.  If Consultant becomes debarred, this Agreement shall terminate automatically without any further action or notice by TetraLogic.  If Consultant receives notice as set forth in clause (b) above, TetraLogic shall have the right to terminate the Consultant’s engagement under this Agreement immediately.
		

		
			 
		

		
			

		 

		

			-3-

		

 

11.       Remedies.  Consultant understands and agrees that the Confidential Information being provided under this Agreement is of a special and unique character and that TetraLogic has made a substantial investment in developing the information.  Consultant further acknowledges that irreparable harm will result to TetraLogic in the event of Consultant’s breach, or threatened breach, of this Agreement.  In such event, TetraLogic, its agents and representatives shall be entitled to specific performance and/or injunctive relief without any requirement to post a bond as a condition to remedy any such breach.  Such remedy shall not be deemed to be the exclusive remedy for any such breach of this Agreement but shall be in addition to all other remedies available at law or in equity.  Consultant further agrees that no failure or delay by TetraLogic, its agents, or representatives in exercising any right, power or privilege under this Agreement shall operate as a waiver thereof, nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any right, power or privilege under this Agreement.  Each and all of the several rights and remedies provided for in this Agreement shall be cumulative.  No one right or remedy shall be exclusive of the others or of any right or remedy allowed in law or in equity.
		

		
			 
		

		
			12.       Disclaimer.  TetraLogic makes no representations or warranties as to the accuracy or completeness of Confidential Information provided under this Agreement.  TetraLogic shall not have any liability to either the Consultant or any of its Representatives resulting from the use of Confidential Information.  Nothing herein shall constitute any representation or warranty with respect to the infringement of any patent or other rights of TetraLogic or a third party.
		

		
			 
		

		
			13.       Release.  In further consideration for the payments to be made by Company to Consultant pursuant to the terms of this Agreement, Consultant on his own behalf and together with his heirs, assigns, executors, agents and representatives hereby generally releases and discharges the Company and its predecessors, successors (by merger or otherwise), parents, subsidiaries, affiliates and assigns, together with each and every of their present, past and future officers, managers, directors, shareholders, members, general partners, limited partners, employees and agents and the heirs and executors of same (herein collectively referred to as the "Releasees") from any and all suits, causes of action, complaints, obligations, demands, common law or statutory claims of any kind, whether in law or in equity, direct or indirect, known or unknown (hereinafter "Claims"), which the Consultant ever had or now has against the Releasees, or any one of them occurring up to and including the date of the this Agreement.  Notwithstanding anything herein to the contrary, the Consultant's release is not and shall not be construed as a release of any future claim by the Consultant against the Company, to the extent a claim may otherwise exist, for indemnity, contribution or cost of defense in connection with the Consultant being made a party to a suit initiated by or on behalf of a third party, which suit is based, in whole or in part, upon the work performed by the Consultant for the Company within the scope of the Consultant's position and duties with the Company as a consultant, employee or officer, or any alleged misconduct by the Consultant within the scope of any former position and duties as an officer or employee of the Company.  This release specifically includes, but is not limited to:
		

		
			 
		

		
			a.         any and all Claims for wages and benefits including, without limitation, salary, stock options, stock, royalties, license fees, health and welfare benefits, severance pay, vacation pay, and bonuses; any and all Claims for wrongful discharge, breach of contract, 

		 

		

			-4-

		

 

whether express or implied, and Claims for breach of implied covenants of good faith and fair dealing;
		

		
			 
		

		
			b.         any and all Claims for alleged employment discrimination on the basis of race, color, religion, sex, age, national origin, veteran status, disability and/or handicap, in violation of any federal, state or local statute, ordinance, judicial precedent or Employee order, including but not limited to claims for discrimination under the following statutes: Title VII of the Civil Rights Act of 1964, 42 U.S.C. §2000e et seq.; the Civil Rights Act of 1866, 42 U.S.C. §1981; the Civil Rights Act of 1991; the Age Discrimination in Employment Act, as amended, 29 U.S.C. §621 et seq.; the Older Workers Benefit Protection Act 29 U.S.C. §§ 623, 626 and 630; the Rehabilitation Act of 1972, as amended, 29 U.S.C. §701 et seq.; the Americans with Disabilities Act, 42 U.S.C. §12101 et seq.; the Family and Medical Leave Act of 1993, 29 U.S.C. §2601, et seq.; the Fair Labor Standards Act, as amended, 29 U.S.C. §201, et seq.; the Fair Credit Reporting Act, as amended, 15 U.S.C. §1681, et seq.; and the Employee Retirement Income Security Act of 1974, as amended, 29 U.S.C. §1000, et seq. ("ERISA") or any comparable state statute or local ordinance;
		

		
			 
		

		
			d.         any and all Claims under any federal or state statute relating to employee benefits or pensions;
		

		
			 
		

		
			e.         any and all Claims in tort, including but not limited to, any Claims for assault, battery, misrepresentation, defamation, interference with contract or prospective economic advantage, intentional or negligent infliction of emotional distress, duress, loss of consortium, invasion of privacy and negligence; and
		

		
			 
		

		
			f.         any and all Claims for attorneys' fees and costs.
		

		
			 
		

		
			The Consultant understands that the release of Claims contained in this Agreement extends to all of the aforementioned Claims and potential Claims which arose on or before the date of this Agreement, whether now known or unknown, suspected or unsuspected, and that this constitutes an essential term of this Agreement.  The Consultant further understands and acknowledges the significance and consequences of this Agreement and of each specific release and waiver, and expressly consents that this Agreement shall be given full force and effect to each and all of its express terms and provisions, including those relating to unknown and uncompensated Claims, if any, as well as those relating to any other Claims specified herein.  The Consultant hereby waives any right or Claim that the Consultant may have to employment, reinstatement or re-employment with the Company.
		

		
			 
		

		
			14.       Governing Law and Jurisdiction.  This Agreement shall be construed and enforced in accordance with the laws of the Commonwealth of Pennsylvania, without regard to the conflict of law principles of Pennsylvania or any other jurisdiction.  Any legal proceeding relating to this Agreement shall be instituted exclusively in the United States District Court for the Eastern District of Pennsylvania or in any court of general jurisdiction in Chester County, Pennsylvania, and Consultant hereby consents to the personal and exclusive jurisdiction of such court and hereby waives any objection that Consultant may have to the laying of venue of any such proceeding and any claim or defense of inconvenient forum.
		

		
			 
		

		
			15.       Miscellaneous.
		

		
			 
		

		
			(a)        TetraLogic and Consultant agree that TetraLogic is under no obligation to produce any documents or information to Consultant and this Agreement does not create or 

		 

		

			-5-

		

 

imply such an obligation.  TetraLogic shall disclose only such information or documents as it may, in its sole discretion, deem appropriate.  In the event TetraLogic discloses information or document such disclosure shall not create or imply an obligation on behalf of TetraLogic to disclose additional information or documents on the same subject matter, related subject matter, or otherwise.
		

		
			 
		

		
			(b)         Nothing contained herein shall be construed as a grant to Consultant of any intellectual property rights either by implication, estoppel, or otherwise.  Neither this Agreement nor the disclosure of Confidential Information hereunder shall be construed as granting any right or license under any invention, whether patentable or unpatentable, now or hereafter owned or controlled by TetraLogic.
		

		
			 
		

		
			(c)         Consultant is an independent contractor.  Nothing contained in this Agreement shall create or imply the creation of a partnership or employment relationship between TetraLogic and Consultant.  Neither party shall have any authority to bind the other.  TetraLogic shall not deduct or withhold from any monies payable to Consultant hereunder any amount for any tax or employee benefit.
		

		
			 
		

		
			(d)         If any provision of this Agreement is determined to be void, invalid, unenforceable or illegal for any reason, the validity and enforceability of all of the remaining provisions hereof shall not be affected thereby.
		

		
			 
		

		
			(e)         This Agreement contains the entire agreement and understanding of the parties relating to the subject matter hereof and merges and supersedes all prior discussions, agreements and understandings of every nature between them relating to the subject matter hereof.  This Agreement may not be amended except by written agreement signed by both of the parties hereto.  The waiver of the breach of any term or provision of this Agreement shall not be a waiver of any other or subsequent breach of this Agreement.  This Agreement may be executed in any number of counterparts, each of which when so executed shall be deemed to be an original and when taken together shall constitute the same Agreement.  The obligations of Consultant as set forth herein, other than Consultant’s obligations to perform the Services, shall survive the termination of Consultant’s engagement.  
		

		
			 
		

		
			(f)         TetraLogic may assign this Agreement to, and this Agreement shall bind and inure to the benefit of, any successor to assignee of TetraLogic.  This Agreement shall not be assignable by Consultant without the written consent of TetraLogic.
		

		
			
		

		
			

		 

		

			-6-

		

 

IN WITNESS WHEREOF, the parties have caused this Consulting Agreement to be executed the day and year first written above.
		

		
			 
		

		
			 
		

		
			 
		

			
					
						 

					
					
						 

					
					
						 

					
					
						 

					
					
						 

				
	
					
						TetraLogic Pharmaceuticals Corporation

					
					
						    

					
					
						Consultant

				
	
					
						 

					
					
						 

					
					
						 

					
					
						 

					
					
						 

				
	
					
						By:

					
					
						 

					
					
						 

					
					
						By:

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

					
					
						 

					
					
						 

				
	
					
						Name:

					
					
						J. Kevin Buchi

					
					
						 

					
					
						Name:

					
					
						Peter A. Meyers

				
	
					
						 

					
					
						 

					
					
						 

					
					
						 

					
					
						 

				
	
					
						Title:

					
					
						Chief Executive Officer

					
					
						 

					
					
						Title:

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

					
					
						 

					
					
						 

				
	
					
						Date:

					
					
						April 6, 2016

					
					
						 

					
					
						Date:

					
					
						 

				

		
			 
		

		
			 
		

		 

		

			-7-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00261-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00261-of-00352.parquet"}]]